Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4029370 | 0.88 | HTR1A (0.42) | ANO1 | |
| SCHEMBL4034270 | 0.86 | KMT2A (0.46) | ANO1KMT2AMEN1KCNA5TACR1 | |
| SCHEMBL5149429 | 0.81 | KDM4E (0.40) | KMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL5172047 | 0.81 | CCKBR (0.44) | KMT2AMEN1TACR1KDM4EALDH1A1 | |
| SCHEMBL4599804 | 0.81 | CCKBR (0.44) | KMT2AMEN1TACR1KDM4EALDH1A1 | |
| SCHEMBL4029965 | 0.78 | CDK4 (0.47) | ANO1KMT2AMEN1ALDH1A1 | |
| SCHEMBL4632724 | 0.77 | GPR84 (0.40) | KMT2AMEN1KDM4EMAPK1CYP2D6 | |
| SCHEMBL14610432 | 0.75 | ADRB3 (0.43) | TACR1 | |
| SCHEMBL5149356 | 0.75 | KDM4E (0.38) | CNR2KMT2AMEN1CFTRKDM4E | |
| SCHEMBL5149347 | 0.75 | KDM4E (0.38) | CNR2KMT2AMEN1CFTRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060573-A1 | Acyltryptophanols | FSHR, NPY1R, NPY2R | ANO1 2687/4885CNR2 127/4885KMT2A 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.